Breast cancer immune response. 3D transparent tumour tomography image of a breast cancer specimen, showing T cells (yellow, red and blue) attacking th
Breast cancer immune response. 3D transparent tumour tomography image of a breast cancer specimen, showing T cells (yellow, red and blue) attacking the tumour after treatment. This is a HER2-positive breast cancer (human epidermal growth factor receptor 2). The cytotoxic T cells are defined by their cluster of differentiation protein co-receptors: CD3 (yellow), CD8 (red) and CD31 (blue). The tumour had been treated with radiation and a PD-L1 (programmed death-ligand 1) immune checkpoint blockade therapy. Studying how such anti-tumour immune responses can be triggered may lead to better treatments. This image is of a mouse model of breast cancer.
Size: 4704px × 3744px
Photo credit: © University of Chicago Comprehensive Cancer Center/NATIONAL CANCER INSTITUTE/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: -, -dimensional, -receptors, 1, 2, 3, 3-dimensional, 3d, abnormal, anti-tumour, background, black, breast, cancer, cancerous, cd31, cd8, cells, cluster, condition, death-ligand, differentiation, dimensional, disease, disorder, epidermal, factor, growth, her2, her2-positive, human, immune, immunological, immunology, immunotherapy, malignancy, malignant, medical, medicine, micro-environment, microenvironment, model, mouse, oncology, pd-l1, positive, programmed, proteins, receptor, research, scanner, system, tissue, tme, tomography, transparent, treatments, tumor, tumour, unhealthy
